Figure 6: Impact of GLC Receptor Antagonist on Cardiac Hypertrophy
2019-06-11T07:01:29Z (GMT) by
(A) Representative histological section of ventricle by hematoxylin and eosin staining of the heart from each treatment group as indicated. (B) Tissue weight measured at week 5 post-TAC from each treatment group as indicated, including HW versus BW (HW/BW), left ventricle weight versus BW (LVW/BW), and lung weight versus BW (LW/BW). *p < 0.05 versus sham. (C) Representative images of tissue section of left ventricles stained with wheat germ agglutinin from each treatment group as indicated. (D) Quantification of cardiomyocyte cross-sectional area in left ventricles of hearts from different treatment groups as indicated. *p < 0.05 versus Control, #p < 0.05 versus TAC. Abbreviations as in Figures 1, 3, and 5.